dc.creator | Chacón López-Muñiz, J. I. | es |
dc.creator | Cruz Merino, Luis de la | es |
dc.creator | Gavilá Gregori, J. | es |
dc.creator | Martínez Dueñas, E. | es |
dc.creator | Oliveira, M. | es |
dc.creator | Seguí Palmer, M. A. | es |
dc.creator | Álvarez López, I. | es |
dc.creator | Antolin Novoa, S. | es |
dc.creator | Bellet Ezquerra, M. | es |
dc.creator | López-Tarruella Cobo, S. | es |
dc.date.accessioned | 2024-03-08T15:51:01Z | |
dc.date.available | 2024-03-08T15:51:01Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Chacón López-Muñiz, J.I., Cruz Merino, L.d.l., Gavilá Gregori, J., Martínez Dueñas, E., Oliveira, M., Seguí Palmer, M.A.,...,López-Tarruella Cobo, S. (2019). SEOM clinical guidelines in advanced and recurrent breast cancer (2018). Clinical and Translational Oncology, 21 (1), 31-45. https://doi.org/10.1007/s12094-018-02010-w. | |
dc.identifier.issn | 1699-048X | es |
dc.identifier.issn | 1699-3055 | es |
dc.identifier.uri | https://hdl.handle.net/11441/156029 | |
dc.description.abstract | Although the metastasic breast cancer is still an incurable disease, recent advances have increased signifcantly the time to
progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based
guideline is a valuable document in treatment decision making. The SEOM guidelines are intended to make evidence-based
recommendations on how to manage patients with advanced and recurrent breast cancer to achieve the best patient outcomes
based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the
United States Preventive Services Task Force guidelines methodology was selected as reference. | es |
dc.format | application/pdf | es |
dc.format.extent | 15 p. | es |
dc.language.iso | eng | es |
dc.publisher | Springer | es |
dc.relation.ispartof | Clinical and Translational Oncology, 21 (1), 31-45. | |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Advanced | es |
dc.subject | Loco-regional recurrence | es |
dc.subject | Breast cancer | es |
dc.subject | SEOM | es |
dc.subject | Guidelines | es |
dc.title | SEOM clinical guidelines in advanced and recurrent breast cancer (2018) | es |
dc.type | info:eu-repo/semantics/article | es |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Medicina | es |
dc.relation.publisherversion | https://link.springer.com/article/10.1007/s12094-018-02010-w | es |
dc.identifier.doi | 10.1007/s12094-018-02010-w | es |
dc.contributor.group | Universidad de Sevilla. CTS151: Bioquímica médica. | es |
dc.journaltitle | Clinical and Translational Oncology | es |
dc.publication.volumen | 21 | es |
dc.publication.issue | 1 | es |
dc.publication.initialPage | 31 | es |
dc.publication.endPage | 45 | es |